Prescient Neuro Pharma Inc..
Prescient NeuroPharma is a Canadian biopharmaceutical company
that is engaged in the development and commercialization of
novel therapeutic products to treat cancer and CNS diseases.
Prescientis achieving its objectives in these areas through its
three
operational divisions: Cancer Drugs, CNS Drugs, and Fine
Chemicals.
Cancer - Discovery and clinical development of new anti-cancer
drugs with enhanced therapeutic properties by rational drug
design and medicinal chemistry. The core cancer therapeutic
technology was discovered at the University of British Columbia
and is being commercially developed by IGT.
CNS Disease - Discovery and clinical development of novel
therapeutics for the treatment of disorders of the brain
utilizing capabilities of medicinal chemistry, combinatorial
chemistry and molecular targeting. The therapeutic technology is
based on metabotropic glutamate receptor pharmacology.
Fine Chemicals - A provider of leading edge chemicals and
services to the biotechnology and pharmaceutical industries
worldwide. This division provides Prescient with sales revenue.
Company Details
Year Established:
1992
Number of Employees:
13
Company Information
Kenneth Curry
Title:
Vice President
Area of Responsibility:
Research/Development/Engineering
Telephone:
(604) 822-3503
Fax:
(604) 822-3506
Email:
Click Here
Products
Anhydrovinblastine
Services
Biotechnology